Literature DB >> 9794927

Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues.

T Laskus1, M Radkowski, L F Wang, H Vargas, J Rakela.   

Abstract

The existence of extrahepatic reservoirs of hepatitis C virus (HCV) replication remains highly controversial. We searched for the presence of HCV-RNA negative strand in various tissues from eight HCV-infected patients who died of acquired immunodeficiency syndrome (AIDS)-related complications. Negative-strand RNA was detected by a Tth-based reverse-transcriptase polymerase chain reaction (RT-PCR), which was optimized for sensitivity and strand specificity on synthetic RNA templates. This assay was capable of detecting about 10(2) genomic Eq molecules of the correct strand while unspecifically detecting >/=10(8) genomic Eq molecules of the incorrect strand. Negative-strand viral RNA was detected in all but one liver, in lymph nodes (5 cases), in pancreas (5 cases), in adrenal gland (2 cases), in thyroid (2 cases), in bone marrow (1 case), and in spleen (1 case). These data suggest a possible presence of HCV replication sites outside the liver, at least in AIDS patients. Whether these findings relate to various extrahepatic manifestations of HCV infection remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9794927     DOI: 10.1002/hep.510280531

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

1.  Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication.

Authors:  T Laskus; M Radkowski; L F Wang; M Nowicki; J Rakela
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 2.  Extrahepatic manifestations of chronic viral hepatitis.

Authors:  N T Pyrsopoulos; K R Reddy
Journal:  Curr Gastroenterol Rep       Date:  2001-02

3.  HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: does it really mean viral replication?

Authors:  V Meier; S Mihm; P Braun Wietzke; G Ramadori
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

4.  Viruses and diabetes: is there something sweet about hepatitis C infection?

Authors:  A L Mason; G J Alexander
Journal:  Ochsner J       Date:  2001-07

5.  Hepatitis C Virus Entry into Macrophages/Monocytes Mainly Depends on the Phagocytosis of Macrophages.

Authors:  Yuan Liu; Wenbo Wang; Ziying Zou; Zonghai Hu; Quanshui Fan; Jie Xiong
Journal:  Dig Dis Sci       Date:  2018-12-10       Impact factor: 3.199

6.  Shear wave elastography (SWE) of the spleen in patients with hepatitis B and C but without significant liver fibrosis.

Authors:  Aleksander Pawluś; Marcin Inglot; Mariusz Chabowski; Kinga Szymańska; Małgorzata Inglot; Mateusz Patyk; Joanna Słonina; Filipe Caseiro-Alves; Dariusz Janczak; Urszula Zaleska-Dorobisz
Journal:  Br J Radiol       Date:  2016-08-16       Impact factor: 3.039

Review 7.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

8.  HCV replication in PBMC and its influence on interferon therapy.

Authors:  Guo-Zhong Gong; Li-Ying Lai; Yong-Fang Jiang; Yan He; Xian-Shi Su
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 9.  HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?

Authors:  J T Blackard; K E Sherman
Journal:  J Viral Hepat       Date:  2008-01-17       Impact factor: 3.728

Review 10.  Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination.

Authors:  Rudruidee Karnchanasorn; Horng-Yih Ou; James Lin; Lee-Ming Chuang; Ken C Chiu
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.